Evidence map›Paper›PMID 35928890›Full record

Observational studyFrontiers in endocrinology2022

Sarcopenic Obesity in Individuals With Neurodisabilities: The SarcObeNDS Study.

Yannis Dionyssiotis, Konstantinos Prokopidis, George Trovas, Maria-Christina Papadatou, Nikolaos Ananidis, Vasileios Tragoulias, Eleni Lazarou, Evangelia Christaki, Marilena Domazou, Antonios Galanos and 1 more

Open access · goldAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Yannis DionyssiotisSpinal Cord Injury Rehabilitation Clinic, Patras University Hospital, Patras, Greece.
Konstantinos ProkopidisDepartment of Musculoskeletal Biology, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom.
George TrovasLaboratory for Research of the Musculoskeletal System, National and Kapodistrian University of Athens, Kifissia, Greece.
Maria-Christina PapadatouLaboratory for Research of the Musculoskeletal System, National and Kapodistrian University of Athens, Kifissia, Greece.
Nikolaos Ananidis1st Physical Medicine and Rehabilitation Department, National Rehabilitation Center EKA, Athens, Greece.
Vasileios Tragoulias1st Physical Medicine and Rehabilitation Department, National Rehabilitation Center EKA, Athens, Greece.
Eleni LazarouRadiology Department, National Rehabilitation Center EKA, Athens, Greece.
Evangelia ChristakiRadiology Department, National Rehabilitation Center EKA, Athens, Greece.
Marilena DomazouRadiology Department, National Rehabilitation Center EKA, Athens, Greece.
Antonios GalanosLaboratory for Research of the Musculoskeletal System, National and Kapodistrian University of Athens, Kifissia, Greece.
Minos TyllianakisSpinal Cord Injury Rehabilitation Clinic, Patras University Hospital, Patras, Greece.
National and Kapodistrian University of Athens · GRGeneral University Hospital of Patras · GRUniversity of Liverpool · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Patients with neurodisabilities (NDS) are prone to alterations in body composition. Sarcopenic obesity (SO) is a condition characterized by increased adipose tissue accompanied by sarcopenia. The aim of this study was to investigate the prevalence of SO in patients with NDS, including stroke, spinal cord, and traumatic brain injuries. Methods: The study Sarcopenic Obesity in NeuroDisabled Subjects (acronym: SarcObeNDS) was a cross-sectional study of hospitalized patients ( Results: A statistically significant difference was found in SMI (7.18 ± 0.95 vs. 6.00 ± 1.13 kg/m Conclusion: In summary, we observed significantly lower BMI and SMI scores in both genders compared to healthy controls. At the clinical level, a timely diagnosis and rapid treatment of sarcopenia and/or obesity in this population may prevent further metabolic repercussions accompanied by higher functional decline and lower quality of life.

Indexed as

Brain Injuries, TraumaticObesitySarcopeniaSpinal Cord InjuriesStrokeAgedBody Mass IndexCross-Sectional StudiesFemaleHumansMaleMiddle AgedQuality of Lifesarcopeniasarcopenic obesityskeletal mass indexspinal cord injurystroketraumatic brain injury

Identifiers

PMID35928890
PMCPMC9343584
OpenAlexW4285793768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.